Catalent Q2 Adjusted EPS $(0.24) May Not Be Comparable To $(0.02) Estimate, Sales $1.03B Beat $1.01B Estimate
Portfolio Pulse from Benzinga Newsdesk
Catalent (NYSE:CTLT) reported a Q2 adjusted EPS of $(0.24), missing the $(0.02) estimate by 1100%, and a 135.82% decrease from last year's $0.67 EPS. Sales were $1.03B, beating the $1.01B estimate by 2.18%, but down 10.18% from last year's $1.15B.
February 09, 2024 | 1:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Catalent reported a significant miss in Q2 adjusted EPS at $(0.24) versus the $(0.02) estimate and a decrease in sales to $1.03B, though slightly above estimates.
The significant miss in EPS and the decrease in sales year-over-year, despite beating sales estimates, suggest a negative short-term impact on Catalent's stock price. The magnitude of the miss and the comparison to last year's performance are particularly concerning for investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100